George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 413.50
Bid: 414.00
Ask: 418.00
Change: 6.00 (1.47%)
Spread: 4.00 (0.966%)
Open: 411.00
High: 419.00
Low: 411.00
Prev. Close: 407.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital reduction (buy-back programme shares)

27 Jun 2023 18:03

RNS Number : 1106E
Banco Santander S.A.
27 June 2023
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

 

Banco Santander reduces its share capital by 1.64% to cancel the shares acquired in the share buy-back programme carried out between March and April 2023 in the context of the shareholder remuneration applicable to the results of financial year 2022.

On 24 April 2023, the board of directors of Banco Santander resolved to implement the Bank's share capital reduction through a cancellation of own shares approved at the Bank's ordinary general shareholders' meeting held on 31 March 2023 on second call under item 5 A of the agenda (the "Capital Reduction"), subject to obtaining the relevant regulatory authorization.

On 27 June 2023, the European Central Bank granted the authorization required to implement the Capital Reduction in accordance with applicable regulations.

Consequently, Banco Santander's share capital has been reduced by EUR 134,924,476.50 through the cancellation of 269,848,953 own shares, each with a nominal value of EUR 0.50, representing approximately 1.64% of the Bank's share capital prior to the capital reduction. The share capital resulting from the Capital Reduction implementation has been set at EUR 8,092,073,029.50, represented by 16,184,146,059 shares with a nominal value of EUR 0.50 each, all of them of the same class and series. Banco Santander's share capital reduction after the four share buyback programmes against 2021 and 2022 earnings amounts to c. €578 million, therefore the Bank has bought back nearly 7% of its outstanding shares (1,156,495,243 shares) since November 2021.

The purpose of the Capital Reduction is the cancellation of the Bank's own shares, contributing to the remuneration of the Bank's shareholders by increasing the profit per share, a consequence which is inherent to the decrease in the number of shares. The Capital Reduction does not involve the return of contributions, since the Bank is the owner of the cancelled shares, having acquired them within the framework of the share buy-back programme, the beginning and termination of which Banco Santander properly notified to the market through the notice of inside information published on 28 February 2023 with registration number 1784 and the notice of other relevant information published on 21 April 2023 with registration number 22057, respectively.

A reserve for amortised capital has been funded with a charge to the share premium reserve for an amount equal to the nominal value of the cancelled shares (i.e. EUR 134,924,476.50), which may only be used under the same conditions as those required for the reduction of the share capital, in accordance with article 335 c) of the Spanish Companies Law. Consequently, in accordance with article 335 c) of the Spanish Companies Law, the Bank's creditors are not afforded the right of opposition referred to in article 334 of the Spanish Companies Law.

For purposes of the provisions of Section 411 of the Spanish Companies Law and in accordance with Additional Provision One of Law 10/2014 of 26 June on the organisation, supervision and solvency of credit institutions, it is hereby stated for the record that, as the Bank is a credit institution and the other requirements set forth in the aforementioned Additional Provision are met, the consent of the bondholder syndicates for the outstanding debenture and bond issues is not required for the implementation of the reduction.

The announcements of the Capital Reduction will be published in the Official Gazette of the Spanish Commercial Registry and on the Bank's corporate website (www.santander.com) in the coming days.

Thereafter, the public deed regarding the corporate resolutions on the Capital Reduction and amendment of the Bank's By-laws will be granted and subsequently registered with the Commercial Registry of Santander. In addition, the delisting of the 269,848,953 cancelled shares from the Spanish and foreign stock exchanges or stock markets on which the Bank's shares are listed, and the cancellation of the book-entry records of the cancelled shares before the competent bodies will both be requested.

 

Boadilla del Monte (Madrid), 27 June 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IMPORTANT INFORMATION

 

Non-IFRS and alternative performance measures

This document contains financial information prepared according to International Financial Reporting Standards (IFRS) and taken from our consolidated financial statements, as well as alternative performance measures (APMs) as defined in the Guidelines on Alternative Performance Measures issued by the European Securities and Markets Authority (ESMA) on 5 October 2015, and other non-IFRS measures. The APMs and non-IFRS measures were calculated with information from Grupo Santander; however, they are neither defined or detailed in the applicable financial reporting framework nor audited or reviewed by our auditors. We use these APMs and non-IFRS measures when planning, monitoring and evaluating our performance. We consider them to be useful metrics for our management and investors to compare operating performance between periods. Nonetheless, the APMs and non-IFRS measures are supplemental information; their purpose is not to substitute IFRS measures. Furthermore, companies in our industry and others may calculate or use APMs and non-IFRS measures differently, thus making them less useful for comparison purposes. APMs using ESG labels have not been have not been calculated in accordance with the Taxonomy Regulation or with the indicators for principal adverse impact in SFDR. For further details on APMs and Non-IFRS Measures, including their definition or a reconciliation between any applicable management indicators and the financial data presented in the consolidated financial statements prepared under IFRS, please see the 2022 Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the SEC) on 1 March 2023, as well as the section "Alternative performance measures" of Banco Santander, S.A. (Santander) Q1 2023 Financial Report, published on 25 April 2023. These documents are available on Santander's website (www.santander.com). Underlying measures, which are included in this document, are non-IFRS measures.

The businesses included in each of our geographic segments and the accounting principles under which their results are presented here may differ from the businesses included and local applicable accounting principles of our public subsidiaries in such geographies. Accordingly, the results of operations and trends shown for our geographic segments may differ materially from those of such subsidiaries.

 

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

 

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CARDDLFLXQLBBBF
Date   Source Headline
26th Apr 202411:28 amRNSBuyback programme: transactions 18-25 Apr
23rd Apr 202411:03 amRNSNotice of First Quarter 2024 Results
18th Apr 202411:04 amRNSBuyback programme: transactions 11-17 Apr
11th Apr 202411:07 amRNSBuyback programme: transactions 3-10 Apr
3rd Apr 202411:10 amRNSBuyback programme: transactions 21Mar-2Apr
2nd Apr 20245:07 pmRNSTotal Voting Rights
22nd Mar 20242:27 pmRNS2024 AGM - Resolutions
22nd Mar 20247:00 amRNSSantander is on its track to meet its 2024 targets
21st Mar 202410:52 amRNSBuyback programme: transactions 14-20 Mar
19th Mar 20249:47 amRNS2023 UK Annual Report
18th Mar 20245:46 pmRNSDirector/PDMR Shareholding
18th Mar 20245:37 pmRNSDirector/PDMR Shareholding
18th Mar 20245:26 pmRNSDirector/PDMR Shareholding
14th Mar 202411:04 amRNSBuyback programme: transactions 7-13 Mar
12th Mar 20249:30 amRNSForm 8.3 - Spirent Communications plc
7th Mar 202411:05 amRNSBuyback programme: transactions 29 Feb-6 Mar
29th Feb 20242:50 pmRNSTotal Voting Rights
29th Feb 202411:07 amRNSBuyback programme: transactions 20-28 Feb
27th Feb 20245:15 pmRNSDirector/PDMR Shareholding
27th Feb 20245:13 pmRNSDirector/PDMR Shareholding
27th Feb 20245:12 pmRNSDirector/PDMR Shareholding
21st Feb 20243:33 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSNotice of AGM
19th Feb 202411:17 amRNSDividend approval & buyback program implementation
19th Feb 20247:45 amRNSFurther re dividend approval
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNS2023 Results - Press release
31st Jan 20247:00 amRNS2023 Results Report & Earnings Presentation
26th Jan 202411:32 amRNSCapital reduction following completion of program
26th Jan 202411:19 amRNSTransaction in Own Shares
24th Jan 202411:06 amRNSNotice of 2023 Results Presentation
18th Jan 202411:05 amRNSBuyback programme: transactions 11-17 Jan
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.